Cargando…

P1040: FACTORS ASSOCIATED WITH THROMBOSIS IN MYELOFIBROSIS

Detalles Bibliográficos
Autores principales:	Bankar, Aniket, Gupta, Gopila, Cheung, Verna, Claudio, Jaime O., Arruda, Andrea, Tsui, Hubert, Capo-Chichi, Jose-Mario, Sibai, Hassan, Davidson, Marta, Maze, Dawn, Gupta, Vikas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431450/ http://dx.doi.org/10.1097/01.HS9.0000971056.91985.c2

Ejemplares similares

Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study
por: Bankar, Aniket, et al.
Publicado: (2021)

Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort
por: England, James T., et al.
Publicado: (2022)

P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
por: Agustina Perusini, Maria, et al.
Publicado: (2023)

Osteolytic lesion in polycythemia vera: First report and review of literature
por: Cheung, Verna, et al.
Publicado: (2022)

Improved donor chimerism in relapse myelofibrosis post allogenic stem cell transplant with azacitidine and oral decitabine—First case report
por: Cheung, Verna, et al.
Publicado: (2022)

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS
por: Lucijanic, M., et al.
Publicado: (2022)

Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia
por: Tierens, Anne, et al.
Publicado: (2023)

PB2248: BONE MARROW NECROSIS: RARE PRESENTATION OF CHRONIC MYELOID NEOPLASMS SYSTEMIC REVIEW AND CASE REPORT
por: Cheung, Verna, et al.
Publicado: (2023)

1040 ejercicios de fuerza explosiva
por: Rius, Joan (Rius Sant)

Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study
por: Bankar, Aniket, et al.
Publicado: (2023)

Managing Pediatric Cancer Patients in COVID19 Pandemic
por: Garg, Vikas, et al.
Publicado: (2020)

Wiley Tax Preparer: A Guide to Form 1040
por: The Tax Institute at H&R Block
Publicado: (2013)

Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience
por: Alduaij, Waleed, et al.
Publicado: (2018)

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen
por: Chen, Ruiqi, et al.
Publicado: (2020)

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
por: Al Nabhani, Ibrahim, et al.
Publicado: (2022)

P1020: SCREENING FOR PORTAL HYPERTENSION IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
por: Davidson, M., et al.
Publicado: (2022)

Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
por: Guglielmelli, Paola, et al.
Publicado: (2020)

Variant analysis of 1,040 SARS-CoV-2 genomes
por: Rouchka, Eric C., et al.
Publicado: (2020)

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
por: Carobbio, Alessandra, et al.
Publicado: (2023)

Splanchnic Vein Thrombosis in Myelofibrosis—An Underappreciated Hallmark of Disease Phenotype
por: Beleva, Elina A.
Publicado: (2023)

EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
por: Prem, Shruti, et al.
Publicado: (2019)

Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound
por: Bruchhagen, Christin, et al.
Publicado: (2018)

Defining disease modification in myelofibrosis in the era of targeted therapy
por: Pemmaraju, Naveen, et al.
Publicado: (2022)

Measurable residual disease monitoring provides insufficient lead-time to prevent morphological relapse in the majority of patients with core-binding factor acute myeloid leukemia
por: Puckrin, Robert, et al.
Publicado: (2020)

Osteolytic lesions in myelofibrosis
por: Johnson, Isla, et al.
Publicado: (2021)

Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study
por: Falhammar, Henrik, et al.
Publicado: (2018)

Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke
por: Sakai, Nobuyuki, et al.
Publicado: (2022)

Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis
por: Perram, Jacinta, et al.
Publicado: (2022)

Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
por: Verstovsek, S, et al.
Publicado: (2016)

Antibacterial activity of selected commercial products for mouth washing and disinfection, assessed in accordance with PN-EN 1040
por: Tyski, Stefan, et al.
Publicado: (2013)

Modification of Serine 1040 of SIBRI1 Increases Fruit Yield by Enhancing Tolerance to Heat Stress in Tomato
por: Wang, Shufen, et al.
Publicado: (2020)

Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040)
por: Ouh, Yung-Taek, et al.
Publicado: (2021)

SG-APSIC1040: Implementing a quality-improvement approach to surgical-site infection prevention in the Philippines
por: Abustan, Anthony, et al.
Publicado: (2023)

Myelofibrosis
por: Passamonti, Francesco, et al.
Publicado: (2023)

Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosis
por: Qi, Xingshun, et al.
Publicado: (2014)

Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis
por: Rupoli, Serena, et al.
Publicado: (2015)

An interesting story of a clone
por: Juneja, Richa, et al.
Publicado: (2020)

Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
por: Chatterjee, Tathagata, et al.
Publicado: (2013)

MD, run 1040 and 1046, Development of a new program for automatic vertical beam steering to optimise luminosity
por: Hémery, J Y, et al.
Publicado: (1979)

Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
por: Ding, Guanxiong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_22eq3lbe7eufl2c5gl4k44mi2d